Bank of America
PBE icon

Bank of America’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bank of America’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.69M Sell
59,290
-2,441
-4% -$197K ﹤0.01% 3524
2025
Q4 		$5.07M Buy
61,731
+1,813
+3% +$140K ﹤0.01% 3379
2025
Q3 		$4.19M Buy
59,918
+1,453
+2% +$98.2K ﹤0.01% 4186
2025
Q2 		$3.75M Sell
58,465
-7,486
-11% -$464K ﹤0.01% 4175
2025
Q1 		$4.18M Sell
65,951
-3,022
-4% -$203K ﹤0.01% 4003
2024
Q4 		$4.59M Buy
68,973
+2,116
+3% +$146K ﹤0.01% 3682
2024
Q3 		$4.67M Sell
66,857
-6,639
-9% -$460K ﹤0.01% 3797
2024
Q2 		$4.76M Sell
73,496
-6,556
-8% -$415K ﹤0.01% 3671
2024
Q1 		$5.18M Buy
80,052
+8,904
+13% +$579K ﹤0.01% 3577
2023
Q4 		$4.68M Buy
71,148
+4,720
+7% +$274K ﹤0.01% 3605
2023
Q3 		$3.79M Sell
66,428
-2,074
-3% -$126K ﹤0.01% 3660
2023
Q2 		$4.2M Buy
68,502
+6,745
+11% +$421K ﹤0.01% 3574
2023
Q1 		$3.88M Buy
61,757
+2,106
+4% +$136K ﹤0.01% 3760
2022
Q4 		$3.79M Sell
59,651
-649
-1% -$41.2K ﹤0.01% 3655
2022
Q3 		$3.56M Buy
60,300
+12,668
+27% +$781K ﹤0.01% 3698
2022
Q2 		$2.75M Buy
47,632
+4,469
+10% +$257K ﹤0.01% 4005
2022
Q1 		$2.68M Sell
43,163
-3,092
-7% -$189K ﹤0.01% 4289
2021
Q4 		$3.29M Buy
46,255
+3,588
+8% +$260K ﹤0.01% 4059
2021
Q3 		$3.19M Buy
42,667
+244
+0.6% +$18.6K ﹤0.01% 4011
2021
Q2 		$3.28M Buy
42,423
+902
+2% +$67K ﹤0.01% 3899
2021
Q1 		$3.06M Sell
41,521
-9,858
-19% -$746K ﹤0.01% 3874
2020
Q4 		$3.6M Sell
51,379
-225
-0.4% -$14.2K ﹤0.01% 3435
2020
Q3 		$2.92M Sell
51,604
-232
-0.4% -$13.6K ﹤0.01% 3389
2020
Q2 		$3.02M Sell
51,836
-965
-2% -$52.6K ﹤0.01% 3295
2020
Q1 		$2.46M Sell
52,801
-3,387
-6% -$177K ﹤0.01% 3324
2019
Q4 		$3.14M Sell
56,188
-7,896
-12% -$412K ﹤0.01% 3649
2019
Q3 		$3.04M Sell
64,084
-2,770
-4% -$142K ﹤0.01% 3670
2019
Q2 		$3.58M Sell
66,854
-27,947
-29% -$1.45M ﹤0.01% 3542
2019
Q1 		$5.23M Sell
94,801
-1,049
-1% -$55.5K ﹤0.01% 3118
2018
Q4 		$4.51M Buy
95,850
+34,147
+55% +$1.76M ﹤0.01% 3105
2018
Q3 		$3.67M Sell
61,703
-1,830
-3% -$107K ﹤0.01% 3480
2018
Q2 		$3.48M Sell
63,533
-7,067
-10% -$359K ﹤0.01% 3496
2018
Q1 		$3.48M Sell
70,600
-4,572
-6% -$233K ﹤0.01% 3419
2017
Q4 		$3.55M Sell
75,172
-36,457
-33% -$1.71M ﹤0.01% 3441
2017
Q3 		$5.57M Buy
111,629
+222
+0.2% +$10.5K ﹤0.01% 3083
2017
Q2 		$5.09M Sell
111,407
-10,493
-9% -$453K ﹤0.01% 3022
2017
Q1 		$5.16M Buy
121,900
+15,396
+14% +$645K ﹤0.01% 2993
2016
Q4 		$4.13M Sell
106,504
-81,268
-43% -$3.28M ﹤0.01% 3108
2016
Q3 		$7.88M Sell
187,772
-82,880
-31% -$3.4M ﹤0.01% 2444
2016
Q2 		$10M Buy
270,652
+68,679
+34% +$2.69M ﹤0.01% 2189
2016
Q1 		$7.73M Sell
201,973
-34,549
-15% -$1.34M ﹤0.01% 2388
2015
Q4 		$11.9M Sell
236,522
-96,554
-29% -$4.77M ﹤0.01% 2110
2015
Q3 		$15.2M Sell
333,076
-90,772
-21% -$5.07M ﹤0.01% 1833
2015
Q2 		$24.7M Buy
423,848
+17,300
+4% +$989K 0.01% 1250
2015
Q1 		$22.4M Buy
406,548
+83,709
+26% +$4.53M 0.01% 1280
2014
Q4 		$16.2M Buy
322,839
+6,321
+2% +$309K 0.01% 1543
2014
Q3 		$14.6M Sell
316,518
-13,706
-4% -$617K ﹤0.01% 1641
2014
Q2 		$14.4M Sell
330,224
-1,278
-0.4% -$51.8K ﹤0.01% 1639
2014
Q1 		$13.8M Buy
331,502
+30,680
+10% +$1.31M 0.01% 1535
2013
Q4 		$11.1M Buy
300,822
+199,269
+196% +$7.15M ﹤0.01% 1754
2013
Q3 		$3.56M Buy
101,553
+3,126
+3% +$104K ﹤0.01% 2699
2013
Q2 		$2.84M Buy
+98,427
New +$2.8M ﹤0.01% 2826

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Bank of America's PBE Position: Q1 2026 in Review

Bank of America reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 4% in Q1 2026, selling an estimated $197K and leaving 59,290 shares worth $4.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3524.

Bank of America first reported a position in PBE in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.7M in Q2 2015. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.

  • Bank of America held 59,290 shares of Invesco Biotechnology & Genome ETF worth $4.69M as of Q1 2026.
  • Bank of America sold 2,441 Invesco Biotechnology & Genome ETF shares in Q1 2026, an estimated $197K.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3524 holding.
  • Bank of America first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Invesco Biotechnology & Genome ETF position peaked at $24.7M in Q2 2015.
  • 100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.